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Aim: To describe a cognitive-behavioural treatment and clinical outcomes in a series of 
children with functional neurological symptoms (FNS). 
  
Method: Thirty-six children with FNS were assessed and of these twenty-two (13 male, 9 
female) with a mean age 14.5 years (SD=2.6, range 6-17 years) completed treatment with 
cognitive behaviour therapy embedded in routine child and adolescent clinical/systemic 
practice. Treatment outcomes were measured at baseline and post-intervention on the 
Child Global Assessment Scale (CGAS), Strengths and Difficulties Questionnaire (SDQ), Goal 
Based Outcomes (GBO) and Revised Child Anxiety and Depression Scale (RCADS).  
  
Results: Scores on the CGAS improved significantly post-intervention (p<0.001) with 82% of 
participants showing reliable change. Individualised goals (GBO) also showed clinically 
meaningful gains. Standard measures of emotional and behavioural symptoms (SDQ and 
RCADS) did not correlate well with clinical diagnoses, were usually subthreshold at baseline, 
and did not show significant improvement post-intervention. 
 
Interpretation: The outcome of this pilot study suggests that CBT can be effective in the 
rehabilitation of young patients with FNS. Detection of common comorbid psychiatric 
disorders was not assisted by use of standardised measures, although most participants 
were clinically anxious or depressed. More research is needed to understand why children 
with FNS and their parents may not endorse mental health symptoms on questionnaires, 
and to further evaluate interventions within randomised controlled trials.  
 
 
 
Keywords: functional neurological symptoms, conversion disorder, children, adolescents, 
treatment 
 
 
 
 
 
Highlights  
• Cognitive-behavioural treatment for childhood functional neurological symptoms 
is described in a case series. 
• The intervention results in improved functioning 
• The majority of these children had clinical diagnoses of anxiety and/or depression 
• Standard questionnaires do not detect anxiety/depression in this population.   
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1. Introduction 
Functional neurological symptoms (FNS) are a heterogeneous group of conditions 
characterised by presentations of altered neurological function or behavioural changes not 
explained by underlying neurological disease or injury.1 FNS are classified as Functional 
Neurological Symptom Disorder (FNSD) or Conversion Disorder in DSM5.2 Synonyms or 
related phenomena include ‘somatoform’, ’psychogenic’ and ‘medically unexplained 
neurological symptoms’. Common symptom presentations include non-epileptic seizures, 
sensory phenomena, motor phenomena, perceived cognitive problems (such as memory 
loss) and pain.3  
 
Functional symptoms in children present a diagnostic challenge and are often resource 
intensive in the paediatric population.4 There is a lack of data on the incidence, impact, 
associated factors and outcomes of FNS in children.  One study, likely to be a low estimate, 
children reported an incidence of conversion disorder of 1.30/100 000 with the most 
common symptoms being motor weakness, abnormal movements and non-epileptic 
seizures.5 Additionally this study indicated that outcome in terms of FNS symptoms at 12 
month follow-up is generally good although in this study 28% of individuals were diagnosed 
with a new psychiatric disorder at follow-up. This suggests that in children with FNS, 
consideration of comorbid psychiatric conditions is important at assessment and for 
planning treatment.  
 
FNS in the adult population is associated with self-reported disability and significant 
emotional distress and unemployment.6 In the child population FNS are associated with 
significant emotional distress including symptoms of depression and anxiety.7,8 FNS are also 
associated with detrimental impact on family functioning with decreased quality of life 
among parents of affected children9 and increased parental anxiety, depression and 
somatization.10 Children with FNS frequently have reduced school attendance and use 
health services more than control populations. Furthermore, FNS often remain undiagnosed 
and misunderstood and can lead to unnecessary and even harmful investigations.11   
 
Despite the significant burden of FNS, there is a lack of intervention studies. Professionals 
often report uncertainty and unease in managing young people with the 
condition12condition Young people and family members emphasise the lack of 
understanding of FNS among professionals and young people report feeling isolated and 
stigmatised.11 Psychological treatment is seen as key to successful intervention and 
outcome and there may be better outcomes for young people with FNS than adults.8 Recent 
systematic reviews of treatments for other somatic symptom disorders indicate that 
cognitive-behavioural approaches have the strongest evidence for efficacy.13 However, to 
date there have been few trials of treatment in FNS, other than for pain.14 There have been 
some encouraging clinical outcome series including in pain15, including a 2 year follow-up 
study in children with non-epileptic seizures.16 
 
There is a need to develop and  evaluate psychological interventions for FNS in the 
paediatric population. We describe a case series of young people who received 
psychological treatment as part of normal clinical practice. As a naturalistic study, this 
incorporates the heterogeneity seen in this population, including the collaboration needed 
with paediatricians regarding ongoing medical management of co-existing medical problems 
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such as epilepsy. The primary aim is to describe the outcome of a cognitive-behavioural 
intervention for children presenting with FNS. Additional mental health needs are also 
considered.  
 
2. Method 
 
2.1. Setting and participants 
The patients in the case series represent sequential referrals for FNS seen for assessment 
and treatment by the Psychological Medicine Team at Great Ormond Street Hospital (GOSH) 
in London UK. Referrals are for young people aged up to 17 with FNS from both within 
GOSH and from paediatricians and psychiatrists around the UK. At referral the diagnosis of 
FNS has already been established. In all cases the diagnosis has been made clinically, 
following investigations as needed, by experienced paediatricians/paediatric neurologists. 
 
In this case series, FNS are defined as neurological symptoms with no known medical cause, 
or where the degree of symptoms is much greater than would be expected from any known 
medical condition. Children who had a mixture of both medically explained neurological 
conditions (e.g. epilepsy) and FNS (e.g. non-epileptic seizures) are included. There was no 
requirement for children to have a separate mental health diagnosis in addition to FNS and 
children were not ruled out if they had other neurodevelopmental or cognitive difficulties. 
  
Thirty-six patients aged between 6 and 17 years were seen for assessment between 2012 
and 2017 and 33 were offered treatment within the Psychological Medicine Team. Of the 
33, 27 took up the offer of treatment, whilst 6 either declined treatment or dropped out of 
treatment. By 2017, 22  had completed treatment, with 5 still being in treatment. The 22 
patients who had completed treatment are included in the current study (Fig. 1). The 
characteristics of all participants are described in Table 1. 
 
2.2. Assessment   
Patients attended a multi-disciplinary diagnostic assessment, led by a consultant psychiatrist 
or consultant psychologist. Prior to the assessment all relevant medical and mental health 
reports were collated and summarised. The detailed half-day assessment included 
interviewing the parent/carer(s) and child/young person together, as well as individual 
interviews with both. Measures of psychological symptoms and impairment were those 
used as standard in the service at that time with additional measures chosen according to 
individual presentation. The measures used are in line with those recommended by the 
Child and Adolescent Mental Health Service (CAMHS) Outcome Research Consortium 
(CORC) (http://www.corc.uk.net/), a UK collaboration aiming to promote consistent 
outcome measurement in work with children and young people experiencing mental health 
difficulties.  
 
2.2.1. Measures 
Strengths and Difficulties Questionnaire (SDQ) (parent and self-report): The SDQ is an 
emotional and behavioural screening test designed to measure the following 5 areas: 
emotional symptoms, conduct problems, hyperactivity, peer relationship problems and 
prosocial behaviour.17 The scores from four of the subscales are summed to give an overall 
total problems score (range 0-40, higher scores indicate greater difficulties). There is good 
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evidence of adequate internal consistency (test–retest reliability, predictive validity, 
discriminant validity and concurrent validity) to discriminate between clinical and nonclinical 
populations.18 
 
Goal Based Outcomes (GBO): Goal based outcomes measure progress towards the particular 
improvement or goals a young person or their family have chosen to work on with Child and 
Adolescent Mental Health Services (CAMHS).19 It represents a personalised measure of 
functional impairment, targeting change most relevant to the young person and their 
family. It is rated on a 0 to 10 scale (0 is not begun to achieve goal and 10 is really good/goal 
achieved, 5 is halfway). There is currently no data available on the reliability of GBOs but 
progress on goals correlates with symptom improvement, rated both by carers and 
clinicians.20 
 
 
Children's Global Assessment Scale (CGAS): The CGAS is a global clinician rating used to 
assess young people's social, emotional and behavioural functioning from 0 (very poor 
functioning) to 100 (very high functioning).21 The CGAS has been reported to have good 
concurrent and discriminative validity and reliability between raters21 as well as adequate 
test-retest reliability. 
 
 
Revised Child Anxiety and Depression Scale (RCADS) (parent and self-report): The RCADS is a 
47-item self-report age-normed questionnaire, with scales corresponding to separation 
anxiety disorder (SAD), social phobia (SP), generalized anxiety disorder (GAD), panic disorder 
(PD), obsessive compulsive disorder (OCD), and major depressive disorder (MDD).22 Items 
are scored 0–3 (corresponding to “never,” “sometimes,” “often,” and “always”).  The RCADS 
demonstrates sound psychometric properties including reliability,23 predictive validity24 and 
internal consistency.25  
 
2.3. Intervention (see Table 2 for details) 
Following assessment, each participant received individually tailored family-based cognitive 
behaviour therapy (CBT). This included individual treatment sessions with the child, parent 
management sessions, joint family sessions incorporating sessions on psychoeducation and 
seizure management and careful liaison with all relevant parts of the child’s network 
including school. CBT is a widely used psychological treatment that aims to improve day-to-
day functioning as well as physical and emotional wellbeing. In this context it was focussed 
on helping children and their families understand their physical symptoms, the causes of 
them, and learning how to change responses to them if necessary. On average, children 
received 12 sessions of CBT for their FNS. 
 
Many children also had additional mental health conditions for which they also received 
evidence-based CBT treatment. For this reason, the number of treatment sessions varied 
between children. Sessions occurred on a weekly basis until the end of treatment. All 
sessions were conducted by one of four qualified clinical psychologists in the team. The CBT 
protocol incorporated standard CBT principles, and was largely delivered either in the 
presence of parents, or with parents joining for a summary at beginning and ends of 
sessions, as is common practice in CBT with children and adolescents. It has been shown 
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that involving parents in cognitive behavioural therapy, including helping to motivate the 
child and reinforce the new desired behaviours (with for example small rewards) improves 
outcomes.26  
 
None of the patients received other forms of psychotherapeutic intervention. However 
throughout, there was emphasis on involving all other professionals involved in the child’s 
care, the school and the family and other carers. If for example the child was also receiving 
physiotherapy, contact was made to ensure that all clinicians shared an understanding of 
the condition, and communicated as near as possible identically with the family. This was 
facilitated by – for example – ensuring that formulation and summary letters, with key 
management strategies were sent to the whole network. The stages of treatment are 
summarised in Fig. 2 and more details of CBT sessions in Table 2.  Delivery of the 
intervention for each child was personalised so the sequence of sessions may have differed 
for each child. Reasons for this included significant low mood or issues around risk, which 
may have meant that CBT sessions for low mood were started first, followed later by seizure 
management sessions.  
 
The initial phase of treatment consisted of psychoeducation on FNS for all children, their 
families and relevant members of their network. The aim of this psychoeducation was to 
increase children’s and families’ ability to incorporate environmental and psychological 
factors into the explanation of symptoms. This included ensuring an understanding that the 
physical symptoms were serious and would be the focus for intervention. Children and 
families were helped to understand the role of physical, psychological and environmental 
factors in a wide range of health conditions including FNS. 
 
The second phase of treatment involved identifying maintaining factors and stressors in the 
occurrence of symptoms. Families and schools were encouraged not to respond to acute 
events as medical emergencies, but to adopt a calm approach with minimal disruption or 
attention. In parallel, children were encouraged to identify early-warning signs of FNS and to 
begin slowly and systematically re-introducing themselves back into situations they were 
avoiding. Homework was set for the child and family each week, with graded reduction in 
avoidance and functional rehabilitation. Close contact was maintained with schools and 
other key components of the child’s network. Environmental stressors which were identified 
as potentially contributing to the FNS were addressed, for example putting support in place 
for previously unidentified specific learning difficulties, or addressing issues with bullying at 
school.   
 
Finally, co-morbid mental health difficulties were treated with standard evidence-based 
treatments.27 These mental health symptoms had often already been identified as stressors 
contributing to the FNS.  
 
The case vignette below highlights the degree of flexibility and complexity that cases 
incorporated, but also the adherence to a graded exposure based cognitive behavioural 
model, with a focus on reducing avoidance, building resilience and understanding, and 
rehabilitation.  
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Case Vignette 
Sam, a 16 year old boy, was referred with a year long history of episodes confirmed - following video 
telemetry - to be non-epileptic seizures (NES). These occurred primarily during the school day, but 
also at weekends and at home. In the year prior to the onset of NES his school attendance has been 
poor, with frequent absences due to abdominal pain and headaches. 
Initial clinical assessment revealed a boy with long standing anxiety symptoms, currently meeting 
criteria for social anxiety, although he and the family felt that he disliked social environments 
because of worry about seizures. School attendance was very poor, and every time he had a seizure 
at school his parents were called or,  if the episode was prolonged, an ambulance. 
The family understood that epilepsy had been excluded, but found it worrying and puzzling how Sam 
could be having ‘seizures’. They were willing to engage in treatment with the team. 
Initial joint aims were established, which included reducing or eliminating NES and their impact and 
trying to understand why they were happening. Sam also said he would like to feel more confident 
with friends and be able to join a sports club. 
The first phase of treatment included education about NES, with examples for the whole family about 
how physical symptoms can occur in surprising and disruptive ways and in the absence of serious 
underlying disease. Following this, the family understood that NES were not dangerous or life-
threatening. They agreed to school liaison and, over the next 4 weeks, worked with the team and the 
school to change the responses to NES when they occurred in the classroom. With support, including 
a letter form the epilepsy clinical nurse specialist and paediatrician, the school agreed to stop calling 
ambulances for the typical episodes. Friends were encouraged not to make a fuss when Sam was 
experiencing an episode, and rather than trying to comfort him, when he ‘came round’ to join him for 
an activity. 
At home the parents managed to stop shadowing Sam around the house, even though there was a 
scary moment when he had an NES near the top of the stairs and the parents feared he would fall. . 
Weekly telephone support for parents was provided to facilitate this and deal with anxieties as they 
arose. 
The frequency and length of seizures began to decrease. 
In parallel, a cognitive assessment had been carried out, which revealed that Sam had significant 
difficulties with literacy, despite overall being an above average student. Once this had been 
identified, the school allocated 10 minutes each day for a teacher to help Sam interpret written 
instructions. Sam’s parents also arranged some specialist teaching for children with dyslexia. The 
school agreed to apply for extra time for exams. 
Sam continued to be very anxious in social settings but insisted it was because he might be 
embarrassed by having an NES. Without challenging this directly at this stage, his therapy sessions 
now began to include an evidence-based social anxiety module. This incorporated graded therapist-
assisted, in-session exposure, with walks outside the hospital, visits to shops and cafes, asking 
strangers for directions etc., all the time monitoring anxiety. As part of this Sam was encouraged to 
appraise his fear of having seizure and what potential reactions might be. In between sessions Sam 
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and his therapist devised behavioural experiments (exposure tasks) to practice each day at home and 
at school. 
After 8 more weeks of sessions, and two telephone calls to the school to support management of NES 
if they occurred, Sam’s NES had stopped. His social anxiety treatment was going well and he had 
joined a local judo club. 
The remaining 2 sessions focussed on relapse prevention- discussing what the family had learnt 
about how Sam’s body responds to stress and anxiety. There was a review of how he now had a 
better understanding of anxiety and its treatment, the importance of continuing challenge of 
avoidance, what might be future likely triggers and how to deal with them, and how much more 
confident he felt now he was getting regular support for dyslexia. 
A one month and 3 month follow-up appointment were arranged. 
 
2.4. Data Analysis  
Descriptive statistics for total scores on each instrument before and after intervention are 
provided. Due to the small sample size and the heterogeneity of the data , results on the 
CGAS, total SDQ and total RCADS were first analyzed at the individual level by reliable 
change analysis, which determines whether the degree of change on each measure was 
statistically reliable, and not due to measurement-error28. This allows for classification of 
patients as either i) reliable deterioration, ii) no change or iii) reliable improvement. Where 
the majority of participants showed reliable change a group level analysis was then 
performed with total scores compared using Wilcoxon signed ranks test.  
 
As there are no known studies investigating psychometric properties of GBOs we limited 
analysis of this data to a descriptive comparison of change in our series to benchmark data 
(the UK Increasing Access to Psychological Therapies program for children and young people 
- CYP IAPT - data set from 2011 to June 2015 which includes data from 75 separate 
services).29 
 
All statistical analysis was carried out using SPSS version 23 (IBM SPSS Statistics, IBM 
Corporation, Armonk, NY).  
 
2.5. Ethics 
The project was registered with and approved by the Great Ormond Street Hospital Clinical 
Governance and Safety Department as a Service Evaluation.  
  
3. Results  
Twenty-two children underwent and completed treatment within the timescale of the 
study.  
 
 
   
Thirteen of the participants were male and nine were female. Mean age at assessment was 
14.5 years (SD 2.6). Four of the children had an illness duration of less than 1 year, nine 1-2 
years and nine children 2 years or more.  The most frequently occurring FNS subtype was 
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non-epileptic seizures (13) followed by motor symptoms (9). However, the participants 
often presented with symptoms in multiple domains with 15 having symptoms in at least 
two domains.  
 
At initial clinical assessment 18/22 participants met criteria for at least one additional 
psychiatric diagnosis as well as FNS and 10/22 participants met criteria for two or more 
additional psychiatric diagnoses. However, SDQ Total Difficulties Scores showed only 2/22DS 
falling in the clinically impaired range; for the RCADS 4/16 participants had both parental 
and child measures in the clinical range  for either anxiety or depression. 10/17 fell in the 
clinical range for depression on either parent or child report, but only in 3 cases did this 
correlate with a clinical diagnosis of depression. Overall where a clinical diagnosis was given 
only 9/18 cases had at least one corresponding high or clinical score on a relevant 
questionnaire.  
 
Table 3 shows the mean scores of the psychological measures before and after intervention. 
Table 4 shows the goals chosen by participants clustered by the key areas to which they 
relate. 
 
3.1. Individual Level Reliable Change Analysis  
Eighteen of 22 participants showed reliable improvement on the CGAS; three showed no 
change and one showed reliable deterioration. Of the 15 participants who had both before 
and after parent SDQ data, 2 showed reliable improvement, two showed reliable 
deterioration and the remaining 11 showed no change on the total difficulties score. Of the 
15 participants who had both before and after young person SDQ data, 3 showed reliable 
improvement, and the remaining 12 showed no reliable change on the total difficulties 
score. Of the 10 participants with before and after parents RCADS 2 showed reliable 
improvement on the total anxiety and depression score, 2 reliable deterioration and 6 no 
reliable change. Of the 13 with before and after child RCADS, 6 showed reliable 
improvement, 1 reliable deterioration and 7  no reliable change. 
 
Thirteen participants had GBO scores both pre- and post-intervention. The mean GBO at the 
start of treatment was 2.78 (SD 1.69) and had risen to 7.79 (SD 1.90) by the end of 
treatment, giving a mean increase in goal ratings of 5.01 (SD 2.04). This compares to a mean 
increase in goal ratings of 3.7  for the entire CYP-IAPT 2011-2015 data set.  
 
3.2. Group Analysis  
The CGAS score increased significantly (43 to 66 – see Table 2 for details) from pre to post 
intervention (p<0.001) indicating significantly improved functioning.  
 
4. Discussion 
This is one of the first studies to describe a cognitive-behavioural intervention for children 
presenting with functional neurological symptoms (FNS). The resulting significant 
improvement in function provides preliminary evidence that these children respond 
positively to a cognitive behavioural intervention. As described, the therapeutic approach 
closely involved family and school, and was individually tailored to the needs of the child. 
The key approach – promoting change through psychoeducation, behavioural experiments 
(with in-session and between-session practice) and cognitive shifts, followed by relapse 
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prevention – represents a cognitive behavioural framework. Traditional mental health rating 
scales were not helpful in this population, as both children and parents did not endorse 
emotional symptoms on questionnaires, despite clinical evidence of anxiety and depression. 
This confirms other indications that conventional measures of emotional and behavioural 
symptoms, such as the SDQ, lack validity in this population.30  
 
At assessment, CGAS scores ranged from 25 to 65 indicating that all had a significant degree 
of global impairment, including, at the lower end of the range, patients severely affected by 
their symptoms. Despite this and the heterogeneous nature of FNS in the sample, the 
majority showed reliable improvement on the CGAS and on achieving their treatment goals 
(measured by GBOs) suggests that a cognitive behavioural intervention for FNS may help 
children and young people to return to day to day life activities. There is limited research on 
the daily impairment experienced by children with FNS but in adults there is  evidence that 
FNS are associated with self-reported disability and significant emotional distress and 
unemployment31 highlighting the need for, and likely benefits of successful early treatment. 
It needs to be established whether treatment in childhood can reduce or alleviate the 
burden of the FNS and associated disability later in life.  
 
High rates of comorbid psychiatric disorders have been reported in similar series of children 
with functional neurological symptoms, such as non-epileptic seizures.32 Despite 86% of 
participants meeting clinical criteria for at least one mental health disorder, this was rarely 
picked up by questionnaire-based instruments that have been shown to have good 
reliability and specificity in other populations. One explanation for this discrepancy could be  
that children presenting with FNS may be less aware of such symptoms or experience them 
differently from those who have such diagnoses but do not have FNS. There is evidence of 
an association between FNS and alexithymia in the adult population.33 There is however, 
mixed evidence of the association between FNS and alexithymia in children with some 
studies supporting the association34 whereas others suggest that children with physical 
symptoms have difficulty in communicating negative internal states rather than difficulty in 
identifying emotions.35 
 
A second possibility is that participants and their families might under-report psychological 
distress for fear that their difficulties will be seen as “all in their head” and thereby reduce 
access to potential medical treatment. Families certainly report such fears12 and the 
communication of the FNS diagnosis in an empathetic manner has been identified as crucial 
with respect to outcome.36 A third possibility is that the clinical psychiatric diagnoses might 
be incorrect, but these were made by experienced clinicians and the rates of occurring 
mental health diagnoses in this study are in keeping with other studies.8 The lack of 
significant change on the SDQ and RCADS, measures specifically designed to capture mental 
health symptoms through self and parental report, is perhaps not surprising given the lack 
of endorsement and low rates of symptoms at initial assessment. 
 
4.1. Clinical implications and future research  
FNS in children are often under-diagnosed and consequently under-treated. The results of 
this study indicate that children and their parents should be offered a cognitive-behavioural 
intervention. The intervention used here was pragmatically driven by the individual child 
and family’s needs, but broadly based on cognitive behavioural principles. The components 
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of such a package could be more carefully defined and evaluated; for example in adults 
there is emerging evidence for the benefits of making a positive diagnosis of FNS, and 
providing clear and non-judgmental education and access to resources.37,38 One small study 
in young people showed that giving a careful biopsychosocial explanation for (in this case) 
non-epileptic seizures, which incorporated an emphasis on the physical symptoms, and on 
‘believing’ the patient, had beneficial effects.39  
 
There is a need to consider how to assess the frequently occurring mental health symptoms 
before and after treatment in this population given the possible lack of validity of self and 
parental rating scales. It may be that these scales should not be used, and it would be better 
to rely on expert clinical diagnosis.  
 
In the adult population with FNS there is increasing evidence that specific physical 
rehabilitation and psychological interventions alone or in combination can be beneficial 
although clinical trial evidence remains limited.40 It will be useful to explore these 
approaches in children with FNS. Our preliminary case experience appears to confirm that a 
primary focus on the impact of the physical symptoms and their rehabilitation is crucial, 
although following engagement of the family the incorporation of CBT seems to offer 
opportunities to address a range of underlying issues, which might prevent a re-emergence 
of the same or new symptoms in the future.  
 
 
Future needs include: 
• Manualisation of cognitive behavioural protocols for paediatric FNS 
• Randomised controlled trials to further evaluate the efficacy of cognitive-
behavioural interventions; 
• Determination of appropriate measures to assess comorbid mental health conditions 
in children with FNS; 
• The development of validated measures of the symptoms, severity and impact of 
FNS in order to better assess treatment outcomes. 
 
 
4.2. Limitations  
The main limitation of this study is that there is no comparison group and so we cannot 
ascertain that any changes were due to the specific intervention rather than factors relating 
to the assessment or general therapeutic contact. This is a naturalistic sample arising from 
the daily clinical practice of the service, and represents a case series. Twenty-seven patients 
of the thirty three assessed with FNS in this period came into treatment with the team: the 
22 included in this case series and five who are still in treatment. There is a lack of 
information about the outcomes in the six children who did not proceed with treatment and 
the five whose treatment is incomplete. 
The criteria used to select patients for this treatment study were pragmatic, but include: the 
diagnosis being made definitively; families receiving and accepting onward psychological 
referral; families living near enough the hospital to attend for treatment regularly.  So the 
sample reported here is selected from the many patients attending this specialist children’s 
hospital each year. Previous audits and published papers from this specialist hospital 
suggest that about 20% of elective admissions are for medically unexplained symptoms, but 
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this diagnosis is not consistently named or coded, so the numbers are unknown. Previous 
prevalence studies in the hospital have suggested approximately 80 children with functional 
neurological symptoms were seen in a 2 year period.41 This poor classification and data 
collection, as well as poor knowledge in paediatricians regarding onward referral for 
psychological treatment, has been recognised as a barrier to current detection and effective 
management of functional symptoms in children.42 
 
Due to changes in clinical practice over the course of time, not all participants completed 
the same measures with the CGAS being the only measure which all participants had at both 
start and end of treatment. The CGAS was scored by treating clinicians and it would be 
better in future studies if raters of CGAS were independent and unaware of the treatment 
status. The data generated from this study can be considered case series pilot data and 
moving forward it is hoped to develop a treatment manual to ensure fidelity whilst at the 
same time recognising the need for flexibility in this group.  
 
There was no specific measure of FNS included within the case-series. Whilst a number of 
questionnaire measures exist,43 these are symptom checklists and include both medically 
explained and medically unexplained symptoms. These inadequacies with existing 
questionnaire measures, together with the wide range of symptoms reported in this case-
series meant that no such measure was suitable.  
 
5. Conclusions  
The results of this study show that improvements in functioning for children with FNS are 
achievable using a cognitive-behavioural intervention involving affected child and parents. 
There is a need to manualise the treatment protocol and for larger randomised controlled 
trials of this intervention. Additionally there is a need for further research to better 
understand the assessment and subsequent response to treatment of the frequent mental 
health conditions in this population.  
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Fig. 1: Recruitment of children with FNS  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Did not take up offer of treatment 
N = 6 
Treatment not yet complete 
N = 5 
Advice given to local team, no 
treatment offered at GOSH 
N = 3 
Seen for assessment 
N = 36 
Attended sessions and 
treatment complete 
N = 22 
Offered treatment 
N = 33 
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Fig. 2: Management of Functional Neurological Symptoms* 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Children may require all or only some of the elements above depending on clincial need. 
Treatment of Functional Neurological Symptoms (FNS) 
Identification of 
stressors
Family 
management 
• Behaviour 
modification 
• Reduce home anxiety 
Identify and treat any 
co-occurring mental 
health problems 
Support child to return 
to school and age 
appropriate activities 
Diagnosis & Psychoeducation of FNS 
Management of 
FNS 
School 
management 
• Reduce ambulance calls 
• Recognise and reduce 
triggers & reinforcing 
factors 
• Additional educational and 
emotional support 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
19 
 
 
Table 1: Characteristics of the children and young people with Functional Neurological 
Symptoms (FNS) 
Patient  Gender  
Age at 
Assessment  
(Years/Months) 
Duration of 
illness  
FNS  symptoms 
Mental Health 
Diagnosis NES 
Motor  
(including 
weakness, 
paralysis, 
collapses) 
Sensory 
(including 
pain, 
tingling, 
itching) Other*  
1 Male 15:01 >2 years       - 
2  Male 16:06 6-12 months  ✔     
  Depression 
3  Female 06:04 >2 years ✔       - 
4  Female 15:05 
1-2 years ✔ ✔ ✔   
Autism, Social 
Anxiety, Tourette 
Syndrome 
5  Male 15:11 1-2 years ✔ ✔     Social Anxiety 
6  Male 08:11 
1-2 years ✔       
Oppositional Defiant 
Disorder 
7  Female 15:06 1-2 years ✔     ✔ Depression 
8  Male 12:10 
1-2 years         
Generalised Anxiety 
Disorder 
9  Female 14:04 
less than 6 
months 
✔  ✔     
Anxiety, Panic 
Disorder 
10 Male 16:10 >2 years    ✔ ✔   Social Anxiety 
11 Female 14:10 
>2 years  ✔ ✔     
Depression, 
Generalised Anxiety 
Disorder 
12 Male 15:09 
6-12 months    ✔   ✔ 
Depression, Social 
Anxiety 
13 Female  14:09 
1-2 years   ✔     
Depression, 
Generalised Anxiety 
Disorder 
14 Male 12:07 
>2 years ✔     ✔ 
Tourette Syndrome, 
Generalised Anxiety 
Disorder, OCD 
15 Female 15:02 
6-12 months  ✔       
Generalised Anxiety 
Disorder 
16 Male 14:01 
>2 years      ✔ ✔ 
Autism, ADHD, Social 
Anxiety 
17 Female 13:08 1-2 years   ✔     Depression 
18 Female 16:03 
>2 years    ✔ ✔   
Social Anxiety, 
Generalised Anxiety 
Disorder 
19 Female 15:06 
>2 years ✔   ✔   
Generalised Anxiety 
Disorder 
20  Female 16:09 1-2 years  
✔ ✔   ✔ 
Generalised Anxiety 
Disorder, Depression 
21  Female 17:02 >2 years    ✔     - 
22 Female 14:01 1-2 years ✔     ✔ - 
*nodding off to sleep, difficulty recognising faces, headaches, cognitive difficulties 
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Table 2: Details of the cognitive behavioural intervention for FNS 
Session  Key strategies Additional strategies for: 
Child and parents  Clinicians School 
Sessions 1–2 
Education 
 
 
 
 
 
 
 
 
 
• Establish rapport; provide validation and 
reassurance 
• Review problem list; identify areas of most 
distress 
• Provide psychoeducation about FNS and 
treatment 
• Provide general outline for therapy process 
• Support patient to set goals for therapy 
• Emphasize importance of self-monitoring and 
at-home practice 
• Elicit reactions to sessions 
• Discuss diagnosis of FNS and 
opportunity for questions 
•Understand the link between 
emotions and the body   
• Help to alleviate anxiety around 
medical cause 
• Build hope for the future 
• Importance of everyone working 
together 
 
• Speak with the child’s network 
• Create a shared understanding of 
the diagnosis and treatment plan 
• Discuss the potentially adverse 
impact of continued medical 
investigation, which then is not 
indicated on progress 
 
• Help school staff to better understand the 
condition  
• To better understand the link between the 
body and mind 
• Engage them in the process of rehabilitation 
for the child 
• Opportunity for problem-solving day-to-day 
difficulties that may arise 
Sessions 3–5 
Identify stressors 
• Provide relaxation training 
• Develop a hierarchy 
• Begin exposure and response prevention / 
activity scheduling  
• Address any issues related to not completing 
home assignments 
• Work socratically with the child 
to explore what makes symptoms 
better or worse 
• Enquire about potential triggers 
preceding symptom onset 
• Support child to begin thinking of 
ways to problem solve their 
worries 
• Assist parents in identifying 
stressors contributing to the child’s 
symptoms 
• Consider the impact possible 
cognitive difficulties and/or other 
neurodevelopmental difficulties 
might be placing on the child 
• Help school to identify stressors 
• Enquire and hypothesise with staff the 
impact of stress on the child 
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Sessions 6–8 
Symptom control 
and behaviour 
management 
 
• Review homework (i.e., relaxation 
techniques, thought–mood tracking, 
exposure tasks etc.) 
• Teach strategies for problem solving 
• Continue practicing exposure response 
prevention 
• Identify thoughts and challenge unhelpful 
thoughts 
• Help child identify physical 
precipitants of the symptoms  
• Develop ways the child can 
improve symptom control 
• Ensure child is on board with 
school management plan to 
prevent further distress 
• Reflect on the reinforcing nature 
of positive attention towards 
symptoms 
• Support parents to provide 
positive attention and 
encouragement when the child is 
working towards increased 
adaptive functioning,  and reduce 
time spent attending to or speaking 
about medically unexplained 
symptoms 
• Discuss management of symptoms 
across the child’s network 
• Discuss role of unconscious 
learning 
• Build motivation where there is 
ambivalence and/or resistance to 
treatment with the network 
 
• Help school to weigh up risks and benefits 
of management plan 
• Develop a consistent way of responding to 
symptoms with the school 
• Invite school to reflect on any current 
unhelpful management approaches and 
discuss useful alternatives  
• Support school to provide positive attention 
and encouragement when the child is well so 
as to avoid reinforcing symptom maintenance 
Sessions 9–16 
Reestablishment 
of Regular Life 
Routines 
• Review homework (i.e., relaxation techniques 
worry time, problem-solving) 
• Address issues related to not completing 
home assignments 
• Continue exposure tasks and thought 
challenging 
• Teach assertiveness and communication skills 
• Role-play with patient and assign homework 
to practice in real life 
• Elicit reactions to sessions 
• Discuss how to increase pleasant activity 
scheduling 
• Discuss mindfulness and acceptance of 
uncontrollable events 
• Support the child to return to 
school using a graded approach 
• Help the child to think about how 
they will manage the reactions of 
peers 
• Support parents to return to their 
previous work schedules and daily 
routines 
• Help parents to encourage their 
child to return to school using a 
graded approach 
• If required, support parents 
through early period of increasing 
symptoms following 
implementation of the 
management plan 
• Remote support for child’s network 
via phone or email to support any 
difficulties that may arise 
• Keep child’s network up to date 
with progress and or difficulties that 
arise 
• Start preparing any transition 
arrangements that might be in place 
to move child from specialist CAMHS 
(Tier 4) support to local CAMHS (Tier 
3) support  
 
• Help school to understand the factors that 
may hinder reintegration  
• Provide accommodations needed for 
learning, social, or other problems  
• Support schools with allowing the child to 
do more activities independently 
• Help the school to manage reactions of 
peers 
• Remote support for child’s school via phone 
or email to support any difficulties that may 
arise 
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Session 17-20 
Review, relapse 
prevention and 
termination of 
sessions  
• Discuss importance of using all skills learned 
thus far to manage symptoms 
• Move toward termination 
• Review all skills–techniques–strategies 
learned to date 
• Discuss progress made in therapy, areas of 
continued effort, ongoing challenges 
• Elicit reaction to therapy process 
• Final session—termination 
• Provide support to parents to 
problem solve any areas of 
difficulty.  
• Build awareness that new 
symptoms may arise but support 
child and parents to feel 
empowered in managing them 
• Support parents to develop 
consist way of responding with 
wider members of the family 
• Encourage parents to support 
child’s problem and deal with 
worries when they arise to prevent 
relapse 
• Inform the child’s network of the 
progress made and plans for 
discharge 
• Disseminate summary of treatment 
along with recommendations for 
ongoing support for the child if 
needed 
• Support school in maintaining level of 
support for the child in school 
• Build awareness that new symptoms may 
arise in school, but support teachers to feel 
empowered in dealing with them by 
reminding them of strategies already used 
with the child 
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Table 3: Scores on measures of psychological functioning for children with FNS before and 
after treatment   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GBO= Goal Based Outcomes, CGAS= Children's Global Assessment Scale, RCADS= Revised Child Anxiety and 
Depression Scale, SDQ= Strengths and Difficulties Questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
Measure Pre Post 
Mean SD Mean SD 
GBO (n=14) 2.78 1.69 7.79 1.90 
CGAS (n=20) 42.95 7.78 65.55 11.60 
RCADS - Parent 
depression (n=10) 
68.60 10.12 60.00 13.99 
RCADS - Parent anxiety 
(n=10) 
57.40 14.49 55.20 16.70 
RCADS – Parent Total 60.90 4.02 56.30 5.20 
RCADS – Child depression 
(n=13) 
58.80 17.82 60.00 5.63 
RCADS – Child anxiety 
(n=13) 
50.77 18.24 45.38 11.80 
RCADS – Child total 
(n=13) 
52.31 18.58 45.62 12.07 
SDQ - Parent (n=10) 13.06 8.46 12.31 8.36 
SDQ - Self (n=15) 14.33 7.69 12.13 6.70 
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Table 4:  Examples of goals chosen by children and families as target for CBT intervention 
 
To acquire tools/strategies: 
• Improve problem solving skills in 
situations  
• Find and practice ways of sharing my 
emotions with others  
• Make a clear plan for how everyone 
responds to severe headache or 
collapsing  
• To have tools to help cope with the 
headaches (nausea), etc.  
• To find out my strengths and weaknesses 
and strategies that may be useful.  
• Express and manage emotions particularly 
anxiety  
• Have a plan of how to manage them  
 
Reduction in symptoms: 
• To reduce the NES and for them to be less intrusive 
and get in the way of life less  
• Stop seizures  
• Not needing wheelchair 
• Resume walking 
• Free of absent episodes 
• To have fewer severe episodes  
• Understand feeling and to go away 
• Feel less tired day to day  
• Control mood swings  
• Headaches to be less debilitating  
• Be able to walk again  
• Be able to control tics  
• To reduce seizures at home  
• Reduce movements particularly in public 
• Episodes to stop 
Increase in confidence: 
• To have more confidence when talking to 
other people 
• Start staying at home on own  
• See people more  
• Feel less anxious be happier and more 
determination to do things  
• Feel more comfortable around people  
• Do more things with friends  
• Speak more with people my age and 
adults and feel confident doing so  
• Feel more confident/happy in self 
• To be more independent 
• Be more confident talking to people and 
go to more social situations  
 
Return to activities: 
• Return to horse-riding, swimming and join 
drama group 
• Start working out again  
• Be able to draw and write more  
• To return to activities  
 
Progress with school: 
• To be able to be in school for all taught lessons 
• Return to school resume normal education  
• Normal life at home and school  
• Get to attend school 
• Finding out why not doing well in exams and 
coursework  
• Balance school work and life and not set self 
unrealistic expectations 
• To reduce seizures at school 
Increase understanding: 
• Understand what triggers pain and how to 
cope  
• Understand how anxiety related to 
dizziness temper and sadness 
• Understand the episodes more  
• Be less worried about bad things 
happening  
 
 
 
